Home
EXEL
EXEL News

Latest Exelixis Inc. (EXEL) News on July 26, 2024

Argus Research

3 days ago

EXEL: What does Argus have to say about EXEL?

Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

Business Wire

3 days ago

Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

Argus Research

10 days ago

EXEL: Raising target price to $24.00

Argus Research

17 days ago

EXEL: What does Argus have to say about EXEL?

The 23% return delivered to Exelixis' (NASDAQ:EXEL) shareholders actually lagged YoY earnings growth

Simply Wall St.

a month ago

The 23% return delivered to Exelixis' (NASDAQ:EXEL) shareholders actually lagged YoY earnings growth

Morningstar Research

a month ago

Analyst Report: Exelixis, Inc.

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

ACCESSWIRE

2 months ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

Business Insider

2 months ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

GlobeNewswire

2 months ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Motley Fool

2 months ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Unifor members vote to strike at Manitoba Hydro

CNW Group

2 months ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly

AFP

2 months ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Business Insider

2 months ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Here's what to do if you missed out on the massive 54% stock market rally since October 2022

Business Insider

2 months ago

Here's what to do if you missed out on the massive 54% stock market rally since October 2022

Insider Sale: Director Jack Wyszomierski Sells Shares of Exelixis Inc (EXEL)

GuruFocus.com

2 months ago

Insider Sale: Director Jack Wyszomierski Sells Shares of Exelixis Inc (EXEL)

MT Newswires

2 months ago

Exelixis Insider Bought Shares Worth $8,733,955, According to a Recent SEC Filing

Exelixis (EXEL) Down 6.6% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Exelixis (EXEL) Down 6.6% Since Last Earnings Report: Can It Rebound?

Exelixis to Present at the William Blair 44th Annual Growth Stock Conference

Business Wire

2 months ago

Exelixis to Present at the William Blair 44th Annual Growth Stock Conference

Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)

GuruFocus.com

2 months ago

Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)

Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla

Zacks

2 months ago

Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla

MT Newswires

2 months ago

Exelixis Settles Cabometyx Patent Litigation with Cipla

Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA

Business Wire

2 months ago

Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA

Morningstar Research

2 months ago

Analyst Report: Exelixis, Inc.

MT Newswires

2 months ago

Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target

Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

Motley Fool

2 months ago

Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May

Business Wire

3 months ago

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May

Exelixis (EXEL) International Revenue Performance Explored

Zacks

3 months ago

Exelixis (EXEL) International Revenue Performance Explored

Morningstar Research

3 months ago

Analyst Report: Exelixis, Inc.

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript

Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Simply Wall St.

3 months ago

Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

MT Newswires

3 months ago

RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept

Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short

Zacks

3 months ago

Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Exelixis Inc Earnings Call

GuruFocus.com

3 months ago

Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...

Exelixis (EXEL) Q1 2024 Earnings Call Transcript

Motley Fool

3 months ago

Exelixis (EXEL) Q1 2024 Earnings Call Transcript

Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks

3 months ago

Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say

Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts

GuruFocus.com

3 months ago

Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts

MT Newswires

3 months ago

Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours

Associated Press Finance

3 months ago

Exelixis: Q1 Earnings Snapshot

Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update

Business Wire

3 months ago

Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update

Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for

Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?

Zacks

3 months ago

Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?

EXEL vs. REGN: Which Stock Is the Better Value Option?

Zacks

3 months ago

EXEL vs. REGN: Which Stock Is the Better Value Option?

Argus Research

3 months ago

EXEL: What does Argus have to say about EXEL?

Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the benefits of longer-term growth

Simply Wall St.

3 months ago

Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the benefits of longer-term growth

Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024

Business Wire

3 months ago

Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024

EXEL or REGN: Which Is the Better Value Stock Right Now?

Zacks

4 months ago

EXEL or REGN: Which Is the Better Value Stock Right Now?

Insiders Are Dumping These 10 Healthcare Stocks

Insider Monkey

4 months ago

Insiders Are Dumping These 10 Healthcare Stocks

4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Motley Fool

4 months ago

4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Simply Wall St.

4 months ago

Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

30 Biggest Biotechnology Companies in the World

Insider Monkey

4 months ago

30 Biggest Biotechnology Companies in the World

Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?

Zacks

4 months ago

Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

Zacks

5 months ago

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

10 Biotech Stocks with Huge Potential

Insider Monkey

5 months ago

10 Biotech Stocks with Huge Potential

2 Biotech Stocks to Buy Hand Over Fist in March

Motley Fool

5 months ago

2 Biotech Stocks to Buy Hand Over Fist in March

Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report?

Zacks

5 months ago

Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report?

10 Mid-Cap Stocks with Insider Purchases

Insider Monkey

5 months ago

10 Mid-Cap Stocks with Insider Purchases

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success

InvestorPlace

5 months ago

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success

EXEL vs. REGN: Which Stock Is the Better Value Option?

Zacks

5 months ago

EXEL vs. REGN: Which Stock Is the Better Value Option?

Morningstar Research

5 months ago

Analyst Report: Exelixis, Inc.

4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Motley Fool

5 months ago

4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Zacks

5 months ago

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Is Now The Time To Put Exelixis (NASDAQ:EXEL) On Your Watchlist?

Simply Wall St.

5 months ago

Is Now The Time To Put Exelixis (NASDAQ:EXEL) On Your Watchlist?

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March

Business Wire

5 months ago

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March

Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments

GuruFocus.com

5 months ago

Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments

2 Stocks Under $30 to Buy and Hold

Motley Fool

5 months ago

2 Stocks Under $30 to Buy and Hold

Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology

Zacks

5 months ago

Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology

Jim Simons Increases Stake in Exelixis Inc

GuruFocus.com

5 months ago

Jim Simons Increases Stake in Exelixis Inc

The 3 Best Biotech Stocks to Buy in February 2024

InvestorPlace

5 months ago

The 3 Best Biotech Stocks to Buy in February 2024

Exelixis (EXEL) Loses -10.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

5 months ago

Exelixis (EXEL) Loses -10.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

Motley Fool

6 months ago

4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

Down -10% in 4 Weeks, Here's Why You Should You Buy the Dip in Exelixis (EXEL)

Zacks

6 months ago

Down -10% in 4 Weeks, Here's Why You Should You Buy the Dip in Exelixis (EXEL)

Exelixis, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.

6 months ago

Exelixis, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Morningstar Research

6 months ago

Analyst Report: Exelixis, Inc.

3 Attractive Medical Stocks to Buy After Earnings

Zacks

6 months ago

3 Attractive Medical Stocks to Buy After Earnings

EXEL or REGN: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

EXEL or REGN: Which Is the Better Value Stock Right Now?

Exelixis (EXEL) Loses -11.72% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

6 months ago

Exelixis (EXEL) Loses -11.72% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Exelixis Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

6 months ago

Exelixis Full Year 2023 Earnings: EPS Beats Expectations

Morningstar Research

6 months ago

Analyst Report: Exelixis, Inc.

Exelixis (EXEL) Q4 Earnings Beat on Lower R&D Spend, Sales Miss

Zacks

6 months ago

Exelixis (EXEL) Q4 Earnings Beat on Lower R&D Spend, Sales Miss

Exelixis, Inc. (NASDAQ:EXEL) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Exelixis, Inc. (NASDAQ:EXEL) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Exelixis Inc Earnings Call

Exelixis (EXEL) Q4 2023 Earnings Call Transcript

Motley Fool

6 months ago

Exelixis (EXEL) Q4 2023 Earnings Call Transcript

Exelixis (EXEL) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

6 months ago

Exelixis (EXEL) Reports Q4 Earnings: What Key Metrics Have to Say

Exelixis (EXEL) Tops Q4 Earnings Estimates

Zacks

6 months ago

Exelixis (EXEL) Tops Q4 Earnings Estimates

Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More

Zacks

6 months ago

Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February

Business Wire

6 months ago

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

6 months ago

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth

The Zacks Analyst Blog Highlights Royal Caribbean Cruises, Netflix, OneSpaWorld, Pearson and Electronic Arts

Zacks

6 months ago

The Zacks Analyst Blog Highlights Royal Caribbean Cruises, Netflix, OneSpaWorld, Pearson and Electronic Arts

Pearson opens bookings for new PTE Core English proficiency test for Canadian economic migration visa purposes

CNW Group

6 months ago

Pearson opens bookings for new PTE Core English proficiency test for Canadian economic migration visa purposes

Is There Now An Opportunity In Autoliv, Inc. (NYSE:ALV)?

Simply Wall St.

6 months ago

Is There Now An Opportunity In Autoliv, Inc. (NYSE:ALV)?

Here's Why Exelixis (EXEL) is a Strong Value Stock

Zacks

6 months ago

Here's Why Exelixis (EXEL) is a Strong Value Stock

5 Stocks to Buy on Steady Rise in Personal Spending, Income

Zacks

6 months ago

5 Stocks to Buy on Steady Rise in Personal Spending, Income

Big Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline

Fortune

6 months ago

Big Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline

AES Announces Fourth Quarter & Full Year 2023 Financial Review Conference Call to be Held on Tuesday, February 27, 2024 at 10:00 a.m. ET

PR Newswire

6 months ago

AES Announces Fourth Quarter & Full Year 2023 Financial Review Conference Call to be Held on Tuesday, February 27, 2024 at 10:00 a.m. ET

2 Warehouse REITs Yielding Over 3%

Benzinga

6 months ago

2 Warehouse REITs Yielding Over 3%

Quest Diagnostics (DGX) Advances in Cancer Research With New Deal

Zacks

6 months ago

Quest Diagnostics (DGX) Advances in Cancer Research With New Deal

American Express CEO on earnings report card: We will perform in a slowing economy

Yahoo Finance

6 months ago

American Express CEO on earnings report card: We will perform in a slowing economy

F5 (FFIV) to Report Q1 Earnings: What's in the Offing?

Zacks

6 months ago

F5 (FFIV) to Report Q1 Earnings: What's in the Offing?

Business Wire

6 months ago

Texas Pacific Land Corporation Sets Dates for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Share on Social Networks: